FDA declines to issue fines for noncompliant trial reporting
The FDA said it won’t impose fines or take greater enforcement action against clinical trial sponsors when they fail to properly report trial information to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.